
Cigna (CI) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
67.2B
Net Income
1.6B
2.43%
Balance Sheet Metrics
Total Assets
150.7B
Total Liabilities
110.2B
Shareholders Equity
40.4B
Debt to Equity
2.73
Cash Flow Metrics
Operating Cash Flow
-493.0M
Free Cash Flow
1.6B
Revenue & Profitability Trend
Cigna Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 244.4B | 195.2B | 180.0B | 174.3B | 160.6B |
Cost of Goods Sold | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 14.8B | 14.8B | 13.2B | 13.0B | 14.1B |
Other Operating Expenses | 182.5B | 133.8B | 124.8B | 117.6B | 103.5B |
Total Operating Expenses | 197.4B | 148.6B | 138.0B | 130.6B | 117.6B |
Operating Income | - | - | - | - | - |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 1.4B | 1.4B | 1.2B | 1.2B | 1.4B |
Other Non-Operating Income | 185.4B | 137.2B | 128.6B | 121.4B | 107.8B |
Pre-tax Income | 5.3B | 5.5B | 8.4B | 6.8B | 10.9B |
Income Tax | 1.5B | 141.0M | 1.6B | 1.4B | 2.4B |
Effective Tax Rate % | 28.3% | 2.6% | 19.2% | 20.2% | 21.9% |
Net Income | 3.8B | 5.4B | 6.8B | 5.4B | 8.5B |
Net Margin % | 1.5% | 2.8% | 3.8% | 3.1% | 5.3% |
Key Metrics | |||||
EBITDA | - | - | - | - | - |
EPS (Basic) | $12.12 | $17.57 | $21.30 | $15.89 | $23.17 |
EPS (Diluted) | $12.12 | $17.39 | $21.30 | $15.75 | $22.96 |
Basic Shares Outstanding | 283218000 | 293892000 | 313065000 | 337962000 | 364979000 |
Diluted Shares Outstanding | 283218000 | 293892000 | 313065000 | 337962000 | 364979000 |
Income Statement Trend
Cigna Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 7.6B | 7.8B | 5.9B | 5.1B | 10.2B |
Short-term Investments | 665.0M | 925.0M | 905.0M | 920.0M | 1.3B |
Accounts Receivable | 30.4B | 23.4B | 22.4B | 19.6B | 17.2B |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | - | - | - | - | - |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | 118.2B | 119.4B | 124.1B | 125.8B | 124.5B |
Intangible Assets | 29.4B | 30.9B | 32.5B | 34.2B | 35.2B |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | - | - | - | - | - |
Total Assets | 155.9B | - | - | - | - |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 9.3B | 8.6B | 7.8B | 6.7B | 5.5B |
Short-term Debt | 3.0B | 2.8B | 3.0B | 2.5B | 3.4B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | - | - | - | - | - |
Non-Current Liabilities | |||||
Long-term Debt | 28.9B | 28.2B | 28.1B | 31.1B | 29.5B |
Deferred Tax Liabilities | 7.0B | 7.2B | 7.8B | 8.3B | 8.9B |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | - | - | - | - | - |
Total Liabilities | 114.6B | - | - | - | - |
Equity | |||||
Common Stock | 4.0M | 4.0M | 4.0M | 4.0M | 4.0M |
Retained Earnings | 43.5B | 41.7B | 37.9B | 32.6B | 28.6B |
Treasury Stock | 31.4B | 24.2B | 21.8B | 14.2B | 6.4B |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 41.2B | 46.4B | 44.8B | 47.2B | 50.4B |
Key Metrics | |||||
Total Debt | 32.0B | 30.9B | 31.1B | 33.7B | 32.9B |
Working Capital | 0 | 0 | 0 | 0 | 0 |
Balance Sheet Composition
Cigna Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 3.8B | 5.4B | 6.8B | 5.4B | 8.5B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 1.8B | 2.9B | 920.0M | -1.7B | 2.8B |
Operating Cash Flow | 5.5B | 6.6B | 7.2B | 3.7B | 11.1B |
Investing Activities | |||||
Capital Expenditures | -1.4B | -1.6B | -1.3B | -1.2B | -1.1B |
Acquisitions | 390.0M | -434.0M | 4.8B | -1.9B | 5.5B |
Investment Purchases | -2.7B | -5.5B | -4.3B | -6.1B | -6.7B |
Investment Sales | 2.4B | 2.6B | 4.1B | 5.6B | 5.4B |
Investing Cash Flow | -2.2B | -5.2B | 3.2B | -3.5B | 3.1B |
Financing Activities | |||||
Share Repurchases | -7.0B | -2.3B | -7.6B | -7.7B | -4.0B |
Dividends Paid | -1.6B | -1.4B | -1.4B | -1.3B | -15.0M |
Debt Issuance | 4.5B | 1.5B | 0 | 4.3B | 4.9B |
Debt Repayment | -3.0B | -3.0B | -500.0M | -4.6B | -9.4B |
Financing Cash Flow | -7.6B | -4.3B | -11.2B | -8.2B | -8.5B |
Free Cash Flow | 9.0B | 10.2B | 7.4B | 6.0B | 9.3B |
Net Change in Cash | -4.4B | -2.9B | -849.0M | -8.0B | 5.6B |
Cash Flow Trend
Cigna Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
16.28
Forward P/E
9.48
Price to Book
1.97
Price to Sales
0.30
PEG Ratio
9.48
Profitability Ratios
Profit Margin
1.92%
Operating Margin
3.67%
Return on Equity
13.18%
Return on Assets
3.98%
Financial Health
Current Ratio
0.79
Debt to Equity
76.10
Beta
0.48
Per Share Data
EPS (TTM)
$18.23
Book Value per Share
$150.84
Revenue per Share
$961.02
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
ci | 79.2B | 16.28 | 1.97 | 13.18% | 1.92% | 76.10 |
UnitedHealth | 244.5B | 11.69 | 2.58 | 21.65% | 5.04% | 75.58 |
CVS Health | 87.0B | 19.11 | 1.12 | 5.88% | 1.18% | 106.67 |
Elevance Health | 69.7B | 13.14 | 1.59 | 12.42% | 2.83% | 68.84 |
Humana | 33.9B | 21.59 | 1.86 | 9.03% | 1.28% | 70.63 |
Centene | 14.0B | 6.92 | 0.51 | 7.44% | 1.29% | 63.91 |
Financial data is updated regularly. All figures are in the company's reporting currency.